AI assistant
Sending…
ADMA BIOLOGICS, INC. — Director's Dealing 2021
Oct 26, 2021
31261_dirs_2021-10-26_2e1f1d30-d8d8-4132-8751-b5de23274a90.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ADMA BIOLOGICS, INC. (ADMA)
CIK: 0001368514
Period of Report: 2021-10-25
Reporting Person: KWON YOUNG (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-10-25 | Common Stock | P | 100000 | $1 | Acquired | 200000 | Direct |
Footnotes
F1: Represents a purchase from the underwriters in the October 2021 public offering of the issuer.
More from ADMA BIOLOGICS, INC.
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 2
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 4
Annual Report
2026
Apr 15
Proxy Solicitation & Information Statement
2026
Apr 15
Regulatory Filings
2026
Mar 27
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 3